Company intelligence
EASL | The Home of Hepatology
Beating liver disease
About EASL | The Home of Hepatology
EASL, the European Association for the Study of the Liver, founded in 1966, is a medical association dedicated to pursuing excellence in liver research, to the clinical practice of liver disorders, and to providing education to all those interested in hepatology. As of 2022, EASL serves 4,800 members. EASL engages globally with all stakeholders in the field of hepatology, worldwide. Our aim is to spread knowledge and expertise in best practices and the latest scientific breakthroughs in this field. We advocate for the benefit of patients and advise European and national health authorities. EASL runs topical conferences, schools, and related educational meetings. Our journals, the Journal of Hepatology and JHEP Reports, provide an international forum for the publication of original articles, reviews, and letters to the Editor, describing the latest science in hepatology. Our eLearning hub, EASL Campus, offers more than 6,200 resources on hepatology and liver research.
Verified activity
Signals from EASL | The Home of Hepatology
5 published signals
Presence & Recognition
EASL | The Home of Hepatology announced next year's four EASL Schools scheduled for 2027 in Zagreb, Madrid, Rotterdam, and Vienna.
Reported by EASL | The Home of Hepatology
Presence & Recognition
EASL | The Home of Hepatology is hosting a webinar on Wednesday 9 September 2026 at 18:00 CEST titled Genetic testing is transforming the diagnostic approach to rare liver diseases, featuring how modern genomic technologies support the diagnosis of PFIC and navigate challenging genetic findings.
Reported by EASL | The Home of Hepatology
Presence & Recognition
EASL | The Home of Hepatology announced that the EASL Schools 2027 applications are open, with a School on Portal Hypertension scheduled for 23-24 September 2027 in Vienna, Austria.
Reported by EASL | The Home of Hepatology
Presence & Recognition
EASL | The Home of Hepatology reported that the 79th World Health Assembly adopted WHA79, the first global resolution dedicated to steatotic liver disease, in May 2026.
Reported by EASL | The Home of Hepatology
Presence & Recognition
EASL | The Home of Hepatology released an episode of TalkLivertoMe exploring the practical dos and don’ts of acute liver failure care using case-based discussion
Reported by EASL | The Home of Hepatology